Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Rewind Therapeutics has raised further funding that has seen Sunstone Life Science Ventures joining as a new investor. The funding round has seen participation of current investors Boehringer Ingelheim Venture Fund, M. Ventures, PMV, Gemma Frisius Fonds, and CD3/ KU Leuven.